LOAN AND LEASE AGREEMENT Dated as of December 20, 2013 the “Effective Date” by and between ESSEX CAPITAL CORPORATION as “Essex” and REVANCE THERAPEUTICS, INC. as “Company” TOTAL CREDIT AMOUNT: Up to $10,800,000Loan and Lease Agreement • December 31st, 2013 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
Company wishes to acquire certain equipment. Essex is willing to finance that acquisition by lending money to Company to build out and install that equipment and, upon Company’s acceptance of the equipment, by purchasing that equipment and leasing it to Company. The information set forth above is subject to the terms and conditions set forth in the balance of this Agreement. The parties agree as follows:
SECOND AMENDMENT TO LOAN AND LEASE AGREEMENTLoan and Lease Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations
This Second Amendment (the “Second Amendment”) to Loan and Lease Agreement is entered into as of February 26, 2015 (the “Second Amendment Effective Date”) by and between ESSEX CAPITAL CORPORATION (“Essex”) and REVANCE THERAPEUTICS, INC. (“Company”).
FIRST AMENDMENT TO LOAN AND LEASE AGREEMENTLoan and Lease Agreement • December 22nd, 2014 • Revance Therapeutics, Inc. • Pharmaceutical preparations • Essex
This First Amendment to Loan and Lease Agreement is entered into as of December 17, 2014 (the “Amendment”) by and between ESSEX CAPITAL CORPORATION (“Essex”) and REVANCE THERAPEUTICS, INC. (“Company”).
